$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 49/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 49/2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | A | 372.46 | 6,120 | 2,279,455 | 6,120 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 52.03 | 3,100 | 161,293 | 7,226 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 378.27 | 51 | 19,292 | 12,197 | 12.2 K to 12.2 K (-0.42 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 377.38 | 346 | 130,573 | 12,248 | 12.6 K to 12.2 K (-2.75 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 376.27 | 470 | 176,847 | 12,594 | 13.1 K to 12.6 K (-3.60 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 375.58 | 624 | 234,362 | 13,064 | 13.7 K to 13.1 K (-4.56 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 374.82 | 191 | 71,591 | 13,688 | 13.9 K to 13.7 K (-1.38 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Payment of Exercise | F | 377.16 | 1,418 | 534,813 | 13,879 | 15.3 K to 13.9 K (-9.27 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 52.03 | 3,100 | 161,293 | 15,297 | 12.2 K to 15.3 K (+25.42 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Grant | A | 0.00 | 2,500 | 0 | 12,197 | 9.7 K to 12.2 K (+25.78 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Grant | A | 0.00 | 1,020 | 0 | 9,697 | 8.7 K to 9.7 K (+11.76 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 0.00 | 9,086 | 0 | 9,086 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 372.46 | 29,177 | 10,867,265 | 29,177 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 21.25 | 107,655 | 2,287,669 | 0 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 379.14 | 33 | 12,512 | 304,485 | 304.5 K to 304.5 K (-0.01 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 378.38 | 3,602 | 1,362,925 | 304,518 | 308.1 K to 304.5 K (-1.17 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 377.47 | 5,732 | 2,163,658 | 308,120 | 313.9 K to 308.1 K (-1.83 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 376.36 | 13,060 | 4,915,262 | 313,852 | 326.9 K to 313.9 K (-3.99 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 375.55 | 21,910 | 8,228,301 | 326,912 | 348.8 K to 326.9 K (-6.28 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 374.79 | 6,873 | 2,575,932 | 348,822 | 355.7 K to 348.8 K (-1.93 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 373.26 | 632 | 235,900 | 355,695 | 356.3 K to 355.7 K (-0.18 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 377.16 | 55,813 | 21,050,431 | 356,327 | 412.1 K to 356.3 K (-13.54 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 21.25 | 107,655 | 2,287,669 | 412,140 | 304.5 K to 412.1 K (+35.36 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | A | 0.00 | 25,155 | 0 | 25,155 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | A | 372.46 | 81,278 | 30,272,804 | 81,278 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | M | 21.25 | 150,000 | 3,187,500 | 0 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | M | 21.25 | 95,295 | 2,025,019 | 150,000 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | G | 0.00 | 23,367 | 0 | 0 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | G | 0.00 | 23,367 | 0 | 23,367 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 325,986 | 0 | 0 | 326 K to 0 (-100.00 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 2,366 | 0 | 325,989 | 328.4 K to 326 K (-0.72 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 75,036 | 0 | 328,352 | 253.3 K to 328.4 K (+29.62 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 500,000 | 0 | 253,316 | 753.3 K to 253.3 K (-66.37 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 150,722 | 0 | 753,316 | 602.6 K to 753.3 K (+25.01 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 150,722 | 0 | 249,278 | 400 K to 249.3 K (-37.68 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 75,036 | 0 | 0 | 75 K to 0 (-100.00 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Payment of Exercise | F | 377.16 | 77,767 | 29,330,602 | 444,109 | 521.9 K to 444.1 K (-14.90 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Buy | M | 21.25 | 150,000 | 3,187,500 | 521,876 | 371.9 K to 521.9 K (+40.34 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Payment of Exercise | F | 377.16 | 49,405 | 18,633,590 | 371,876 | 421.3 K to 371.9 K (-11.73 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Buy | M | 21.25 | 95,295 | 2,025,019 | 421,281 | 326 K to 421.3 K (+29.23 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 325,986 | 0 | 325,986 | 0 to 326 K |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Grant | A | 0.00 | 10,000 | 0 | 57,951 | 48 K to 58 K (+20.85 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Grant | A | 0.00 | 2,625 | 0 | 47,951 | 45.3 K to 48 K (+5.79 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | EVP General Counsel ... | Grant | A | 0.00 | 2,625 | 0 | 14,438 | 11.8 K to 14.4 K (+22.22 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 273.67 | 4,000 | 1,094,680 | 2,250 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 374.86 | 1,585 | 594,153 | 323 | 1.9 K to 323 (-83.07 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 373.91 | 1,400 | 523,474 | 1,908 | 3.3 K to 1.9 K (-42.32 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 372.75 | 1,015 | 378,341 | 3,308 | 4.3 K to 3.3 K (-23.48 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 273.67 | 4,000 | 1,094,680 | 4,323 | 323 to 4.3 K (+1,238.39 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Grant | A | 0.00 | 5,000 | 0 | 24,973 | 20 K to 25 K (+25.03 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Grant | A | 0.00 | 2,625 | 0 | 19,973 | 17.3 K to 20 K (+15.13 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Grant | A | 0.00 | 5,000 | 0 | 28,251 | 23.3 K to 28.3 K (+21.50 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Grant | A | 0.00 | 2,625 | 0 | 23,251 | 20.6 K to 23.3 K (+12.73 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 0.00 | 25,155 | 0 | 25,155 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 372.46 | 81,278 | 30,272,804 | 81,278 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 21.25 | 187,500 | 3,984,375 | 0 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 21.25 | 124,900 | 2,654,125 | 187,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 377.16 | 97,209 | 36,663,346 | 474,499 | 571.7 K to 474.5 K (-17.00 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 21.25 | 187,500 | 3,984,375 | 571,708 | 384.2 K to 571.7 K (+48.80 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 377.16 | 64,754 | 24,422,619 | 384,208 | 449 K to 384.2 K (-14.42 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 21.25 | 124,900 | 2,654,125 | 448,962 | 324.1 K to 449 K (+38.54 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Grant | A | 0.00 | 2,625 | 0 | 11,380 | 8.8 K to 11.4 K (+29.98 %) |